The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions
碩士 === 國立陽明大學 === 藥理學研究所 === 98 === Zoledronic acid (ZOL) is used for treating bone metastasis, hypercalcemia of malignancy, multiple myeloma, and the related diseases of bone. At present, many studies have reported direct anti-breast cancer effects of ZOL. Combined administration of anticancer agen...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/95527481856730181899 |
id |
ndltd-TW-098YM005550012 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-098YM0055500122015-10-13T18:49:18Z http://ndltd.ncl.edu.tw/handle/95527481856730181899 The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions 探討zoledronicacid在正常氧壓及低氧壓環境下對人類乳癌細胞株之影響及其細胞毒殺作用的分子機制 Chia-Ling Chang 張佳鈴 碩士 國立陽明大學 藥理學研究所 98 Zoledronic acid (ZOL) is used for treating bone metastasis, hypercalcemia of malignancy, multiple myeloma, and the related diseases of bone. At present, many studies have reported direct anti-breast cancer effects of ZOL. Combined administration of anticancer agents with ZOL may improve treatment of osteosarcoma, lung cancer, prostate cancer, and breast cancer. Previously, it was found that the in vivo effective dose of ZOL on cancer cells was lower than that of in vitro experiments. Additionally, anticancer effects of the same drug were different under normoxic and hypoxic conditions. The objective of this study was to compare and examine the anticancer effects and mechanism of ZOL on human breast cancer cells between normoxic and hypoxic conditions. MCF-7, MCF-7/ADR, and MDA-MB-231 cells were treated with 0.1 to 100 μM of ZOL for 24 to 72 hours. Under normoxic condition, ZOL-treatment of MCF-7 cells resulted in a dose- and time-dependent cytostatic effect using MTT and trypan blue exclusion assays. In contrast, ZOL treatment resulted in cytotoxic effect of MCF-7 cells under hypoxic condition. On the other hand, ZOL-treatment of MCF-7/ADR and MDA-MB-231 cells resulted in cytotoxic effect under both normoxic and hypoxic conditions. Flow cytometry analyses of cell cycle in ZOL-treated cells showed that percentages of different phases of cells were increased under normoxic and hypoxic conditions. Moreover, a sub-G0/G1 peak was higher under hypoxic condition than normoxic condition. Western blot analysis revealed the mechanism of ZOL-induced growth inhibition, involved in Akt/mTOR, MAPK and apoptosis pathways. ZOL treatment decreased the level of p-Akt, p-mTOR, p-ERK1/2, survivin, and Bcl-2/Bcl-xL protein and increased the level of caspase 3. Furthermore, ZOL-inhibited the expression of HIF-1α under hypoxic condition. These results suggested that the effect of ZOL-induced cytotoxicity under hypoxic condition better than under normoxic condition. Chin-Wen Chi Hsin-Chen Lee 戚謹文 李新城 2010 學位論文 ; thesis 127 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立陽明大學 === 藥理學研究所 === 98 === Zoledronic acid (ZOL) is used for treating bone metastasis, hypercalcemia of malignancy, multiple myeloma, and the related diseases of bone. At present, many studies have reported direct anti-breast cancer effects of ZOL. Combined administration of anticancer agents with ZOL may improve treatment of osteosarcoma, lung cancer, prostate cancer, and breast cancer. Previously, it was found that the in vivo effective dose of ZOL on cancer cells was lower than that of in vitro experiments. Additionally, anticancer effects of the same drug were different under normoxic and hypoxic conditions. The objective of this study was to compare and examine the anticancer effects and mechanism of ZOL on human breast cancer cells between normoxic and hypoxic conditions. MCF-7, MCF-7/ADR, and MDA-MB-231 cells were treated with 0.1 to 100 μM of ZOL for 24 to 72 hours. Under normoxic condition, ZOL-treatment of MCF-7 cells resulted in a dose- and time-dependent cytostatic effect using MTT and trypan blue exclusion assays. In contrast, ZOL treatment resulted in cytotoxic effect of MCF-7 cells under hypoxic condition. On the other hand, ZOL-treatment of MCF-7/ADR and MDA-MB-231 cells resulted in cytotoxic effect under both normoxic and hypoxic conditions. Flow cytometry analyses of cell cycle in ZOL-treated cells showed that percentages of different phases of cells were increased under normoxic and hypoxic conditions. Moreover, a sub-G0/G1 peak was higher under hypoxic condition than normoxic condition. Western blot analysis revealed the mechanism of ZOL-induced growth inhibition, involved in Akt/mTOR, MAPK and apoptosis pathways. ZOL treatment decreased the level of p-Akt, p-mTOR, p-ERK1/2, survivin, and Bcl-2/Bcl-xL protein and increased the level of caspase 3. Furthermore, ZOL-inhibited the expression of HIF-1α under hypoxic condition. These results suggested that the effect of ZOL-induced cytotoxicity under hypoxic condition better than under normoxic condition.
|
author2 |
Chin-Wen Chi |
author_facet |
Chin-Wen Chi Chia-Ling Chang 張佳鈴 |
author |
Chia-Ling Chang 張佳鈴 |
spellingShingle |
Chia-Ling Chang 張佳鈴 The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions |
author_sort |
Chia-Ling Chang |
title |
The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions |
title_short |
The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions |
title_full |
The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions |
title_fullStr |
The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions |
title_full_unstemmed |
The Differential Effects and Mechanism of Zoledronic Acid-induced Cytotoxicity on Human Breast Cancer Cells under Normoxic and Hypoxic Conditions |
title_sort |
differential effects and mechanism of zoledronic acid-induced cytotoxicity on human breast cancer cells under normoxic and hypoxic conditions |
publishDate |
2010 |
url |
http://ndltd.ncl.edu.tw/handle/95527481856730181899 |
work_keys_str_mv |
AT chialingchang thedifferentialeffectsandmechanismofzoledronicacidinducedcytotoxicityonhumanbreastcancercellsundernormoxicandhypoxicconditions AT zhāngjiālíng thedifferentialeffectsandmechanismofzoledronicacidinducedcytotoxicityonhumanbreastcancercellsundernormoxicandhypoxicconditions AT chialingchang tàntǎozoledronicacidzàizhèngchángyǎngyājídīyǎngyāhuánjìngxiàduìrénlèirǔáixìbāozhūzhīyǐngxiǎngjíqíxìbāodúshāzuòyòngdefēnzijīzhì AT zhāngjiālíng tàntǎozoledronicacidzàizhèngchángyǎngyājídīyǎngyāhuánjìngxiàduìrénlèirǔáixìbāozhūzhīyǐngxiǎngjíqíxìbāodúshāzuòyòngdefēnzijīzhì AT chialingchang differentialeffectsandmechanismofzoledronicacidinducedcytotoxicityonhumanbreastcancercellsundernormoxicandhypoxicconditions AT zhāngjiālíng differentialeffectsandmechanismofzoledronicacidinducedcytotoxicityonhumanbreastcancercellsundernormoxicandhypoxicconditions |
_version_ |
1718037146137264128 |